Search results for "NAPA"

showing 10 items of 33 documents

CanStem303C trial: A phase III study of napabucasin (BBI-608) in combination with 5-fluorouracil (5-FU), leucovorin, irinotecan (FOLFIRI) in adult pa…

2017

TPS3619 Background: Cancer stem cells are considered to be fundamentally important for resistance to therapy, recurrence and metastasis. Napabucasin is a first-in-class cancer stemness inhibitor in development identified by its ability to inhibit STAT3-driven gene transcription and spherogenesis of cancer stem cells (Li et al, PNAS 112(6):1839, 2015). Preclinically, napabucasin sensitizes cancer cells to chemotherapeutics, including 5-FU and irinotecan. Encouraging anticancer activity in advanced CRC was observed in a phase Ib/II (Bendell et al, GI ASCO 2017) study of 63 pts with disease control rate (DCR) of 93% (28/30) and overall response rate (ORR) of 33% (10/30) in FOLFIRI-naïve pts w…

0301 basic medicineOncologyCancer Researchmedicine.medical_specialtybusiness.industryColorectal cancerCancermedicine.diseaseMetastasisIrinotecan03 medical and health sciences030104 developmental biology0302 clinical medicineOncologyCancer stem cellFluorouracil030220 oncology & carcinogenesisInternal medicinemedicineFOLFIRIbusinessNapabucasinmedicine.drugJournal of Clinical Oncology
researchProduct

Cerebrospinal fluid T-regulatory cells recognize Borrelia burgdorferi NAPA in chronic Lyme borreliosis.

2013

The NapA protein of B. burgdorferi is essential for the persistence of spirochetes in ticks. One of the most intriguing aspects of NapA is its potential to interfere with the host immune system. Here, we investigated the role of the acquired immune responses induced by NapA in the cerebrospinal fluids (CSF) of patients with chronic Lyme borreliosis. We evaluated the cytokine profile induced in microglia cells and CSF T cells following NapA stimulation. We report here that NapA induced a regulatory T (Treg) response in the CSF of patients with chronic Lyme borreliosis and it is able to expand this suppressive response by promoting the production of TGF-β and IL-10 by microglia cells. Collect…

AdultMaleT regChemokineT-LymphocytesT cells; T reg; Borrelia; Lyme; Adult; Bacterial Proteins; Cerebrospinal Fluid; Chemokines CXC; Chronic Disease; Female; Humans; Interleukin-10; Lyme Disease; Male; Microglia; Middle Aged; T-Lymphocytes Regulatory; Transforming Growth Factor betaImmunologyT cellsT-Lymphocytes RegulatoryImmune systemLyme diseaseBacterial ProteinsTransforming Growth Factor betaImmunology and AllergyMedicineHumansBorrelia burgdorferiCerebrospinal FluidPharmacologyNAPACXCLyme DiseasebiologyMicrogliabusiness.industryBorreliaTransforming growth factor betaMiddle Agedbiology.organism_classificationmedicine.diseaseRegulatoryInterleukin-10Interleukin 10medicine.anatomical_structureImmunologyChronic Diseasebiology.proteinLymeFemaleMicrogliaChemokinesbusinessChemokines CXC
researchProduct

Disabilità e dolore: il caso della cannabis terapeutica. Fisionomia e limiti del diritto alla cura nel decreto del Ministero della Salute 9 novembre …

2022

Il contributo illustra l’originale struttura del mercato della cannabis terapeutica, ricostruendo la legislazione italiana in materia, di cui si mette in luce la dubbia compatibilità  con i principi di libera circolazione e di concorrenza. La specialità del settore è comunemente giustificata alla luce delle esigenze di salute pubblica, dell’ordine pubblico e della pubblica sicurezza la cui tutela è sottesa anche ai più recenti interventi normativi: specialità che non consente tuttavia di giudicare la regolazione della cannabis terapeutica conforme all’interpretazione consolidata degli articoli 49, 52, 56, 106 T.f.Ue e alla altrettanto stabile giurisprudenza della Corte costituzionale italia…

Cannabis cannabis terapeutica marijuana canapa mercato farmaceutico cure palliative terapia del dolore disabilitàSettore IUS/10 - Diritto Amministrativo
researchProduct

Relative Abundances of Proteobacterial Membrane-Bound and Periplasmic Nitrate Reductases in Selected Environments

2007

ABSTRACT Dissimilatory nitrate reduction is catalyzed by a membrane-bound and a periplasmic nitrate reductase. We set up a real-time PCR assay to quantify these two enzymes, using the narG and napA genes, encoding the catalytic subunits of the two types of nitrate reductases, as molecular markers. The narG and napA gene copy numbers in DNA extracted from 18 different environments showed high variations, with most numbers ranging from 2 × 10 2 to 6.8 × 10 4 copies per ng of DNA. This study provides evidence that, in soil samples, the number of proteobacteria carrying the napA gene is often as high as that of proteobacteria carrying the narG gene. The high correlation observed between narG an…

DNA BacterialMolecular Sequence DataEnvironmentNitrate reductaseNitrate ReductasePlant RootsPolymerase Chain ReactionApplied Microbiology and BiotechnologyMicrobial Ecologychemistry.chemical_compoundBacterial ProteinsNitrateProteobacteriaGeneSoil Microbiology[SDV.EE]Life Sciences [q-bio]/Ecology environmentNAPAEcologybiologyMembrane ProteinsPeriplasmic spacebiology.organism_classificationBiochemistrychemistryPeriplasmic ProteinsProteobacteriaBacteriaDNAFood ScienceBiotechnologyApplied and Environmental Microbiology
researchProduct

Benefici e svantaggi delle eparine a basso peso molecolare

2014

Premesse e Scopo dello studio: Le eparine a basso peso molecolare vengono utilizzate per la prevenzione e il trattamento della coagula- zione del sangue, l’obiettivo è quello di ridurre al minimo gli effetti collaterali in seguito alla somministrazione delle varie molecole. Metodi e Risultati: L’analisi stata effettuata presso il Dipartimento di Chirurgia Generale e di Urgenza dell’A.O. Ospedali riuniti Villa Sofia - Cervello, su un campione di circa 80 pazienti con età compresa tra i 35-80 anni, 50 sono di sesso femminile e 30 sono di sesso maschile, sono stati riscontrati dall'osservazione effettuata i seguenti effetti collaterali: per quanto riguarda la Parnaparina e la Bemiparina sangui…

Eparine a basso peso molecolareParnaparinaBemiparinaSettore BIO/14 - Farmacologia
researchProduct

Mínguez, Víctor; Rodríguez Moya, Inmaculada. Napoleón y el espejo de la Antigüedad. Arqueología de las imágenes del poder

2015

En Napoleón y el espejo de la Antigüedad, el Dr. Víctor Mínguez y la Dra. Inmaculada Rodríguez culminan una intensa labor investigadora iniciada con el proyecto I+D “Arqueología de las imágenes del poder. El arte imperial romano como modelo iconográfico en las Cortes Europeas desde el Renacimiento a Napoleón” (P1.1B2012-02), integrado en el Plan de Investigación de la Universitat Jaume I y dirigido por el Dr. Víctor Mínguez. Encabezado por la presentación del prestigioso doctor Philippe Bordes, uno de los máximos especialistas en historia del arte de la Revolución francesa y de la época del Imperio, este ambicioso proyecto elabora un exhaustivo recorrido a través del estudio de los modelos …

European courtsRoman Imperial artUNESCO::HISTORIA::Historia por especialidades::Historia del arteArte imperial romanoNapoleonNapoleón BonaparteCortes EuropeasS. XV-XIXFifteenth to nineteenth centuryImages of powerArtículoImágenes del poder:HISTORIA::Historia por especialidades::Historia del arte [UNESCO]
researchProduct

Nusidawimai szwento Karawimo [Geschichte des heiligen Krieges]

1814

Grāmatā par varonīgo prūšu u.c. cīņām pret Napoleonu. Minēta Leipcigas kauja (Bataille de Leipzig), arī Tautu kauja (Völkerschlacht bei Leipzig, Битва народов), kas bija nozīmīga kauja pret Napoleona Bonaparta spēkiem no 1813. gada 16. oktobra līdz 19. oktobrim. Kauja norisinājās Saksijas karalistē, pie Leipcigas. Tajā Sestā koalīcija (Krievijas Impērija, Austrijas impērija, Prūsijas karaliste un Zviedrija) pieveica Napoleona spēkus un pēc kaujas Napoleons zaudēja kontroli pār teritorijām uz austrumiem no Reinas. Pēc kaujas beidza pastāvēt arī Reinas konfederācija. Grāmatā arī Kristiana Daniela Hasenšteina (Christian Daniel Hassenstein) tulkotas un sarakstītas dziesmas par varonīgajiem cīnī…

Geschichte Europas. 19. Jh.Kriegsgeschichte Europas. 19. Jh.Eiropas karu vēsture. 19. gs.:HUMANITIES and RELIGION::History and philosophy subjects::History subjects::History [Research Subject Categories]PrußenNapoléon Bonaparte (1769-1821)prūšiHassenstein Christian DanielEiropas vēsture. 19. gs.Napoleons Bonaparts (1769-1821)Hasenšteins Kristians Daniels
researchProduct

Cotejo de la proclamacion de Josef Napoleon intruso, con la de nuestro amado y legitimo rey Don Fernando VII

Peu d'impremta pres del colofó La proclamació "in absentia" de Ferran VII com a Rei en Madrid va tindre lloc el 24 d'Agost (citat al text) de 1808 Signatures: [ ]2 Text a dues columnes

Josep Bonaparte rei d'Espanya 1768-1844 Poesia.Ferran VII rei d'Espanya 1784-1833 Poesia.Poesia castellana 1808-1814.
researchProduct

La mala conciencia acusa al turulato rey Pepe.

Precedeix al tit.: Comedia nueva en dos actos titulada

Josep Bonaparte rei d'Espanya 1768-1844 Teatre
researchProduct

Kalmbergin kartasto R VII : List 1

1855

Kivennapamaastokartat1850-lukuUusikirkko Vpl.kartat
researchProduct